Galapagos NV (NASDAQ: GLPG) was downgraded by analysts at Kepler Capital Markets from a "hold" rating to a "reduce" rating.
Galapagos to Present Results of Pioneering Innovation in Cancer Cell Therapy at ASH 2024
Galapagos NV (NASDAQ: GLPG) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $30.00. They now have a "sector perform" rating on the stock.
Galapagos Reports Third Quarter 2024 Financial Results and Provides Business Update
Galapagos grants an investor a seat on its board [Seeking Alpha]